DUBLIN–( ORGANIZATION CORD)– The “Semaglutide Market Dimension and Share Evaluation – Development Patterns and Projection Record 2025-2033” record has actually been contributed to ResearchAndMarkets.com’s offering. The Semaglutide market will certainly get to US$ 61.7 billion in 2033 from US$ 27.15 billion in 2024 and is expected to expand at a CAGR of 9.55% from 2025 to 2033. As the occurrence of excessive weight and kind 2 diabetic issues rises, the efficiency of semaglutide in glycemic control and weight monitoring is driving market need. Expanding a.
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/semaglutide-market-forecast-and-competitive-landscape-report-2025-2033-featuring-novo-nordisk-eli-lilly-and-co-astrazeneca-biocon-johnson-and-johnson-pfizer-abbvie-and-sanofi-researchandmarke/
